Iodixanol shortage — BE supply status & alternatives

Iodixanol

—

🇦🇺 AUST R 49594 · GE Healthcare Australia Pty Ltd

In supply · Australia

Visipaque

In supply · 🇦🇺 Australia · short in🇩🇪 DE🇧🇪 BE

In supply in Australia

Reading today’s signals…

✓ Can I substitute?

In supply

no shortage substitution needed

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Therapeutic category
Active ingredient (INN)	Iodixanol
Brand names	Visipaque

Controlled substance	No

Marketing-authorisation holders	GE Healthcare Australia Pty Ltd, FRESENIUS KABI USA, LLC, FRESENIUS KABI CANADA LTD

Registrations on file	18

Patient information leaflet (PIL)	Not on file

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Other markets

🇫🇷 FR

€39.23

Retail price

Global API supply base 🇺🇸 FDA Drug Master Files · active Type II

4 API manufacturers

Manufacturers with an active Type II Drug Master File — i.e. cleared to supply this active ingredient into the US market. A proxy for how concentrated the global manufacturing base is.

Moderate concentration risk

Jiangsu Hengrui Pharmaceuticals CO LTDZhejiang Starry Pharmaceutical CO LTDSuzhou Ryway Biotech CO LTDJiangsu Yutian Pharmaceutical CO LTD

Manufacturing countries: China · Source: FDA List of Drug Master Files

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders18 registrations · 3 MA holders

Product	Strength	Form	Market	MA holder	Status
VISIPAQUE iodixanol	32.6g	—	🇦🇺 AU	GE Healthcare Australia Pty Ltd	Active
VISIPAQUE iodixanol	65.2g	—	🇦🇺 AU	GE Healthcare Australia Pty Ltd	Active
VISIPAQUE iodixanol	97.8g	—	🇦🇺 AU	GE Healthcare Australia Pty Ltd	Active
VISIPAQUE iodixanol	130.4g	—	🇦🇺 AU	GE Healthcare Australia Pty Ltd	Active
VISIPAQUE iodixanol	27.5g	—	🇦🇺 AU	GE Healthcare Australia Pty Ltd	Active
VISIPAQUE iodixanol	55g	—	🇦🇺 AU	GE Healthcare Australia Pty Ltd	Active
VISIPAQUE iodixanol	82.5g	—	🇦🇺 AU	GE Healthcare Australia Pty Ltd	Active
VISIPAQUE iodixanol	110g	—	🇦🇺 AU	GE Healthcare Australia Pty Ltd	Active
VISIPAQUE iodixanol	5.5g	—	🇦🇺 AU	GE Healthcare Australia Pty Ltd	Active
VISIPAQUE iodixanol	11.0g	—	🇦🇺 AU	GE Healthcare Australia Pty Ltd	Active
VISIPAQUE iodixanol	6.5g	—	🇦🇺 AU	GE Healthcare Australia Pty Ltd	Active
VISIPAQUE iodixanol	13.0g	—	🇦🇺 AU	GE Healthcare Australia Pty Ltd	Active
VISIPAQUE iodixanol	22.0g	—	🇦🇺 AU	GE Healthcare Australia Pty Ltd	Active
VISIPAQUE iodixanol	26.1g	—	🇦🇺 AU	GE Healthcare Australia Pty Ltd	Active
Iodixanol	270mg/mL	injection	🇺🇸 US	FRESENIUS KABI USA, LLC	Active

+3 more registrations on file

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.